DA
IDXX icon

DCM Advisors’s Idexx Laboratories IDXX Stock Holding History

DCM Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-840
Closed -$553K – 201
2021
Q4 		$553K Hold
840
– – 0.16% 131
2021
Q3 		$522K Hold
840
– – 0.2% 132
2021
Q2 		$531K Buy
840
+240
+40% +$133K 0.3% 106
2021
Q1 		$294K Hold
600
– – 0.17% 154
2020
Q4 		$300K Buy
+600
New +$268K 0.17% 146

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

DCM Advisors's IDXX Position: Q1 2022 in Review

DCM Advisors sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 840 shares — an estimated $553K sold.

DCM Advisors first reported a position in IDXX in Q4 2020 and held it in 5 quarters. The position peaked at $553K in Q4 2021. 1,032 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

  • DCM Advisors reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
  • DCM Advisors sold 840 Idexx Laboratories shares in Q1 2022, an estimated $553K.
  • DCM Advisors first reported a position in Idexx Laboratories in Q4 2020 and held it in 5 quarters.
  • DCM Advisors's Idexx Laboratories position peaked at $553K in Q4 2021.
  • 1,032 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on DCM Advisors's 13F filing for Q1 2022, filed 9 May 2022.